Drugdiscovery >> Clinical Trials >> News
5263
Views
New Alzheimer drug enters Phase 3 program - drugdiscovery.com
New Alzheimer drug enters Phase 3 program - drugdiscovery.com


Lundbeck/ Otsuka Pharmaceutical’s investigational compound, Lu AE58054, is entering the first out of four Phase 3 clinical trials for the treatment of Alzheimer's disease. Lu AE58054 has a different proposed mechanism of action than currently available Alzheimer's medications.
Read More >>


Tags: Lundbeck, Otsuka, Alzheimer disease, investigational drug, new drug, treatment, clinical trial - October 11, 2013
Related Articles
2804
Views
Interferon-free hepatitis coctail of AbbVie enters Phase III Interferon-free hepatitis coctail of AbbVie enters Phase III
The new drug of AbbVie has entered clinical trial phase II. It cures hepatitis C, and provides a ribavirin-free, all-oral treatment without interferon. Read More >>

Tags: interferon, hepatitis C, clinical trial, Phase III

4480
Views
Ovarian cancer drug demcizumab enters Phase 2 Ovarian cancer drug demcizumab enters Phase 2
OncoMed Pharmaceuticals’ stem cell product candidate, demcizumab (OMP-21M18) has entered Phase 1b/2 clinical trial and will be tested in combination with paclitaxel in patients with platinum-resista Read More >>

Tags: OncoMed, oncomed, demcizumab, ovarian cancer, fallopian tube cancer, primary peritoneal cancer

6838
Views
 Melflufen enters Phase II study in the treatment of multiple myeloma patients Melflufen enters Phase II study in the treatment of multiple myeloma patients
Melflufen, also known as J1, will be used in combination with dexamethasone for late stage, relapsing or relapsing/refractory patients with multiple myeloma. The aim of this phase study is to determi Read More >>

Tags: melflufen, J1, multiple myeloma, late stage, clinical trial

7744
Views
AstraZeneca’s olaparib to enter Phase 3 clinical program for ovarian cancer AstraZeneca’s olaparib to enter Phase 3 clinical program for ovarian cancer
AstraZeneca has initiated the enrollment of patients for a Phase III (SOLO) clinical program of its drug olaparib. The drug will be tested as a maintenance monotherapy in patients with BRCA mutated ov Read More >>

Tags: ovarian cancer, clinical trial, olaparib, AstraZeneca, SOLO, BRCA mutation, PARP inhibitor

6264
Views
Melanoma implantable skin cancer vaccine enters Phase 1 clinical trial Melanoma implantable skin cancer vaccine enters Phase 1 clinical trial
The experimental vaccine consists of a disk-shaped, biodegradable sponge which contains growth factors and components of each patient's tumors aiming to recruit and reprogram a patient’s own immune Read More >>

Tags: melanoma, cancer, clinical trial, skin, implant, implantable, vaccine

6948
Views
New succes on Phase II trial of a new GBM vaccine New succes on Phase II trial of a new GBM vaccine
ImmunoCellular Therapeutics Ltd's GBM vaccine proved to be successful on Phase II clinical trial. GBM is one of the most offensive cancer of the brain. There are few therapeutic options for this, so t Read More >>

Tags: GBM, Brain Cancer, ImmunoCellular Therapeutics, Ltd, Phase II. clinical trial.

1462
Views
Phase III trial of Amgen's drug was an outstanding success Phase III trial of Amgen's drug was an outstanding success
Evolocumab, the new drug of Amgen has gone through Phase III. clinical trial. The result is a statistically significant reduction in low-density lipoprotein cholesterol. The new drug seems to be 66% m Read More >>

Tags: drug, competitior, cholesterol, Amgen

5736
Views
Cystic fibrosis drug candidate shows positive results in Phase 1A Cystic fibrosis drug candidate shows positive results in Phase 1A
Celtaxsys’s experimental drug CTX-4430, intended for the treatment of pulmonary inflammation in CF, showed to be safe in healthy volunteers in the first of two clinical trials in Phase 1 program. Read More >>

Tags: Cystic fibrosis, CF, clinical trial, experimental drug, Celtaxys

3334
Views
Phase-III trial of new sarcoma drug Phase-III trial of new sarcoma drug
620 patients were enrolled to the Phase-III trial of TH-302. The trial is led by Threshold Pharmaceuticals. The new drug might open a new chapter in the history of advanced soft-tissue sarcoma. Read More >>

Tags: soft tissue sarcoma, phase-III trial, soft tissue

5980
Views
Boehringer Ingelheim’s  COPD drug successful in  Phase 3 studies Boehringer Ingelheim’s COPD drug successful in Phase 3 studies
The results show that olodaterol Respimat, in addition to usual care, provides statistically significant improvements in lung function in patients with COPD, compared to usual care alone. Read More >>

Tags: olodaterol Respimat, COPD, drug, new treatment, Boehringer Ingelheim, Boehringer, clinical trial

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013